Similar articles

• Fox rabies in India.

  Wilde H. Wilde H. Clin Infect Dis. 2005 Feb 15;40(4):614-5. doi: 10.1086/427706. Epub 2005 Jan 26. Clin Infect Dis. 2005. PMID: 15712087 No abstract available.
• Postexposure rabies prophylaxis.

  Ruck B, Marcus S. Ruck B, et al. J Emerg Med. 1997 May-Jun;15(3):378. doi: 10.1016/s0736-4679(97)00015-2. J Emerg Med. 1997. PMID: 9258793 No abstract available.
• Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group.

  Lang J, Simanjuntak GH, Soerjosembodo S, Koesharyono C. Lang J, et al. Bull World Health Organ. 1998;76(5):491-5. Bull World Health Organ. 1998. PMID: 9868840 Free PMC article. Clinical Trial.
• Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virus.

  Brochier B, Boulanger D, Costy F, Pastoret PP. Brochier B, et al. Vaccine. 1994 Nov;12(15):1368-71. doi: 10.1016/0264-410x(94)90143-0. Vaccine. 1994. PMID: 7887012 Review.
• Rabies.

  Pastoret PP. Pastoret PP. Virus Res. 2002 Jan 30;82(1-2):61-4. doi: 10.1016/s0168-1702(01)00388-4. Virus Res. 2002. PMID: 11885952 Review. No abstract available.